New York Life Investment Management’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
New York Life Investment Management's AGL Position: Q1 2024 in Review
New York Life Investment Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 946 shares — an estimated $297K sold.
New York Life Investment Management first reported a position in AGL in Q4 2023 and held it in 1 quarter. The position peaked at $297K in Q4 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.
- New York Life Investment Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
- New York Life Investment Management sold 946 Agilon Health shares in Q1 2024, an estimated $297K.
- New York Life Investment Management first reported a position in Agilon Health in Q4 2023 and held it in 1 quarter.
- New York Life Investment Management's Agilon Health position peaked at $297K in Q4 2023.
- 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.
Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.